PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Are patient partners a necessity in research?

Honest feedback from the scientific community

2024-06-14
(Press-News.org) Sjögren’s disease is a systemic autoimmune disorder that often causes sicca symptoms – or dryness of the eyes and mouth, alongside many other complications such as fatigue, pain, and neurological manifestations. There are treatments that help with symptoms, but none that address the underlying disease processes.3 One key issue in developing new treatments is that Sjögren’s can differ from person to person – and that makes it hard to measure and compare outcomes in a clinical trial.

 

NECESSITY is an interventional trial looking at new clinical endpoints in Sjögren’s disease. This is an international project involving eight European countries, and coordinated by Professor Xavier Mariette. The aim is to identify sensitive endpoints that could be used in clinical trials to assess the efficacy of new medicines. In addition, the project hopes to find biological markers that could be used to identify specific subgroups of people with different disease types.3 Unusually, the project has gathered a consortium of 25 partners across academia and industry – including representatives from patient associations. This is a challenging initiative, but one which could add value and highlight patients’ unique experience and expertise around Sjögren’s and its numerous unmet needs. To assess the merits of working with patient advisory groups in this way, a survey was sent to each of the other partners. The intention was to collect a scientific point of view, as well as to identify obstacles and areas for improvement.

 

The main challenges identified included differences in perspectives and perceptions of Sjögren’s disease, as well as the need to go beyond strictly scientific considerations in order to include patient opinions and implement their ideas. Another concern was to ensure that patients find their place within the consortium amongst scientists, and about the time sometimes needed to explain technical aspects to ensure effective collaboration. Addressing these challenges will be important for future projects.

 

But when looking at the benefits of working with patient partners, there were some noteworthy findings. For example, a majority of respondents favoured working with patients to validate unmet needs – especially those around symptoms and care expectations. Some people also expressed the view that patient partners provide moral support, boost motivation, and retain empathy within the consortium. Over 95% of respondents stated they would be willing to seek out patient partners in the future, and view them as genuine research partners.

 

Overall, the NECESSITY consortium appears to have been a success, and could provide the basis for a collaborative model to address clinical research in the future, helping to answer questions from the perspective of both the patient and the medical community.

 

Source

Bouillot C, Piatrova A. Myths vs Realities: An honest feedback from the scientific community on collaboration with patients partners in the NECESSITY research project. Presented at EULAR 2024; OP0286-PARE.

Ann Rheum Dis 2024; DOI: 10.1136/annrheumdis-2024-eular.2931.

 

References

1. Patient Research Partners (PRP). https://www.eular.org/pare-patient-research-partners

 

2. de Wit MPT, et al. European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects. Ann Rheum Dis 2011;70(5):722–26.

 

3. NECESSITY Project. https://www.necessity-h2020.eu/#necessity-project

 

About EULAR

EULAR is the European umbrella organisation representing scientific societies, health professional associations and organisations for people with rheumatic and musculoskeletal diseases (RMDs). EULAR aims to reduce the impact of RMDs on individuals and society, as well as improve RMD treatments, prevention, and rehabilitation. To this end, EULAR fosters excellence in rheumatology education and research, promotes the translation of research advances into daily care, and advocates for the recognition of the needs of those living with RMDs by EU institutions.

 

Contact

EULAR Communications, communications@eular.org

 

Notes to Editors

EULAR Recommendations

EULAR School of Rheumatology

EULAR Press Releases

 

END


ELSE PRESS RELEASES FROM THIS DATE:

Encouraging cooperation in inflammatory arthritis

2024-06-14
Inflammatory arthritis describes a group of diseases caused by an overactive immune system. The different types of inflammatory arthritis include rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. The most common symptoms are joint pain and stiffness. Pain is the predominant symptom in the majority of people with inflammatory arthritis, which contributes to the global burden of rheumatic and musculoskeletal conditions.1 Knowledgeable support can reduce ...

Protection against disease and treatment toxicity

2024-06-14
Autologous hematopoietic stem cell transplantation (aHSCT) for SSc has been proven the most effective treatment strategy with regard to overall and event free survival in selected patients.2 But a key limitation is its toxicity, and new treatment options are needed. Two abstracts presented at the 2024 EULAR congress in Vienna focused on novel approaches.   Jörg Henes presented on behalf of the AST MOMA investigators. This prospective, open-label, study evaluated the feasibility of aHSCT in patients with impaired lung or heart function, and also ...

Does BMO induced by mechanical stress progress to structural lesions?

2024-06-14
BMO in the sacroiliac joint on MRI is present in up to 84% of people with non-radiographic axSpA – but it is also often seen in a non-inflammatory setting, such as in women after childbirth.1,2 As back pain is common after childbirth, differential diagnosis with axSpA is an important issue in clinical practice.1 In axSpA, active inflammatory lesions are likely to progress to structural lesions over time – particularly fat lesions and erosions. But it is not known whether the same is true for BMO induced by mechanical stress. In June 2024, EULAR – The European Alliance of Associations for Rheumatology – held its annual congress ...

Is fish intake linked to JIA?

2024-06-14
In 2019, a Swedish prospective birth cohort study of over 15,000 children showed that consuming fish at least once a week during pregnancy and during the first year of life was associated with up to a 5-fold increased risk of JIA, compared to those with fish consumption less than once a week. This increased risk was primarily attributed to elevated exposure to heavy metals.1 Now, new research shared at the 2024 congress of EULAR – The European Alliance of Associations for Rheumatology – is investigating ...

Unpicking the complexity of systemic sclerosis

2024-06-14
SSc is a connective tissue disease with variable clinical presentation. It may affect the skin, blood vessels, heart, lungs, kidneys, gastrointestinal tract, and musculoskeletal system – and this complexity and diversity makes it challenging to treat.2 This clinical heterogeneity in SSc may be partially explained by SSc-specific antibodies, but a better understanding of additional risk factors and patient stratification is still needed. Three abstracts shared at the 2024 EULAR congress present a selection of new clinical research to enrich knowledge ...

Group tests novel therapeutic strategy to minimize progression of Duchenne muscular dystrophy

2024-06-14
In an animal model of Duchenne muscular dystrophy, Brazilian researchers tested a therapy that combines photobiomodulation using laser light or light-emitting diodes (LEDs) with idebenone, an antioxidant compound investigated for application in neurodegenerative diseases. As reported in an article published in the journal PLOS ONE, the strategy prevented muscle degeneration and improved regenerative capacity in the muscle fibers affected by the disease. Duchenne muscular dystrophy is the most common and most severe form of childhood muscular dystrophy and most often ...

NMDP and CIBMTR share new, promising stem cell transplantation trial data using mismatched, unrelated donors at the 2024 EHA Congress

2024-06-14
MINNEAPOLIS, June 14, 2024 — NMDPSM, a global nonprofit leader in cell therapy, and the CIBMTR® (Center for International Blood and Marrow Transplant Research®) announced interim results from the ACCESS trial as an oral abstract during the European Hematology Association (EHA) Annual Meeting in Madrid, Spain. The study demonstrated that adults with hematologic malignancies who received peripheral blood stem cell (PBSC) transplant from HLA-mismatched unrelated donors (MMUD) followed by post-transplant cyclophosphamide (PTCy) graft-versus-host-disease (GvHD) prophylaxis exhibited a 79% overall survival (OS), the primary ...

Global trial confirms benefit of antacids on bleeding prevention for ventilated patients

Global trial confirms benefit of antacids on bleeding prevention for ventilated patients
2024-06-14
Hamilton, ON (June 14, 2024) – A widely available drug helps prevent upper gastrointestinal bleeding in critically ill adults on a breathing machine, according to the results of a global study and meta-analysis led by researchers at McMaster University. The research, published on June 14, 2024 in The New England Journal of Medicine and NEJM Evidence, investigated the effect of the gastric acid suppressant pantoprazole, which is primarily used to treat heartburn caused by gastroesophageal reflux disease (GERD). Patients ...

Tea crop saviors: Genomic insights into the tea grey geometrid's survival strategy

Tea crop saviors: Genomic insights into the tea grey geometrids survival strategy
2024-06-14
In a breakthrough that could redefine tea crop protection, a new study has shed light on the genetic makeup of the tea grey geometrid, Ectropis grisescens. Through the re-sequencing of 43 genomes, scientists have mapped out the pest's population structure and its remarkable adaptation to tea crops, offering new avenues for managing this agricultural adversary. Amidst the lush tea plantations, a microscopic menace looms—the tea grey geometrid, a pest that can decimate tea yields with its insatiable appetite. The economic and qualitative havoc wreaked by this insect has prompted an urgent call for innovative pest control solutions. However, the genomic secrets ...

Cervical cancer screening rates among rural and urban females

2024-06-14
About The Study: This repeated cross-sectional study found that past-year Papanicolaou testing rates were lower in 2022 than 2019, pointing to a need to increase access to screenings to prevent an uptick in cervical cancer incidence. Rural-vs-urban differences in 2022 indicate a need to specifically target rural females.  Corresponding Author: To contact the corresponding author, Tyrone F. Borders, Ph.D., email ty.borders@uky.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.17094) Editor’s ...

LAST 30 PRESS RELEASES:

What 3I/ATLAS tells us about other solar systems

University of Cincinnati allergist receives $300,000 grant to research rare esophageal disease

Ohio State scientists advance focus on nuclear propulsion

New study reveals a hidden risk after cervical cancer

Environment: Indigenous Amazon territories benefit human health

Zoology: Octopuses put their best arm forward for every task

New research reveals wild octopus arms in action

NEW STUDY: Across eight Amazon countries, forests on Indigenous lands reduce spread of 27 diseases – From respiratory ailments to illnesses spread by insects, animals

How many ways can an octopus flex its supple arms? Now we know

Analysis of ‘magic mushroom’ edibles finds no psilocybin but many undisclosed active ingredients

Modifiable parental factors and adolescent sleep during early adolescence

Excess HIV infections and costs associated with reductions in HIV prevention services in the us

Clocks created from random events can probe ‘quantumness’ of universe

Schaeffer Center white paper outlines FDA reforms to boost pharmaceutical innovation and expand access 

Michael Welsh, MD, wins Lasker Award for cystic fibrosis research

The metals reveal: The Bronze Age was more connected than we previously thought

Portable light-based brain monitor shows promise for dementia diagnosis

AI tools uncover new link between idiopathic pulmonary fibrosis and aging

Researchers revive the pinhole camera for next-gen infrared imaging

Gender gap in Africa’s water leadership undermines fair policymaking

City of Hope Research Spotlight, August 2025

NIH funds study of type 1 diabetes development

Preventing recidivism after imprisonment

Mass General Brigham’s Kraft Center announces winner and finalists of the 2025 Kraft Prize for Excellence and Innovation in Community Health

Researchers develop novel approach for experimentally measuring the Unruh effect with high accuracy

Americans’ knowledge of civics increases, Annenberg survey finds

Multifaceted benefits of ginseng and its extracts: a brief review of immunomodulation, quality of life improvement, and antitumor potential

Korea University study reveals hidden complexity in recurrent brain tumors

How an immune cell receptor dampens the fight against fungal infection

SeoulTech researchers uncover high PAHs in common foods

[Press-News.org] Are patient partners a necessity in research?
Honest feedback from the scientific community